Physician profile
Ragheb Harb
NPI 1457779118
$2,978.09
in general payments reported to CMS, 2019-2025
20 companies · $2,147 in 2025
The $2,147 reported for 2025 was more than what 94% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $327 · 2024: $505 · 2025: $2,147.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,554 · Food and Beverage: $1,424.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,554.24 |
| Food and Beverage | $1,423.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,624.65 | 2023-2025 | Gallant, Coroflow, Mitraclip |
| Medtronic, INC. | $430.03 | 2023-2025 | Azure Xt Dr Mri Surescan, Linq II, Corevalve Evolut R |
| Stryker Corporation | $221.83 | 2025 | Flowtriever, Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Boston Scientific Corporation | $172.01 | 2024-2025 | Watchman Flx |
| E.R. Squibb & Sons, L.L.C. | $110.16 | 2023 | Camzyos |
| Novartis Pharmaceuticals Corporation | $81.45 | 2023-2025 | |
| Teleflex LLC | $40.21 | 2023-2025 | Guideliner |
| Astrazeneca Pharmaceuticals LP | $39.10 | 2024 | Andexxa |
| Abiomed | $39.00 | 2024 | |
| Edwards Lifesciences Corporation | $30.49 | 2025 | Sapien 3 Ultra Resilia |
| Kiniksa Pharmaceuticals, LTD. | $21.39 | 2023 | Arcalyst |
| Cardiva Medical, INC. | $21.18 | 2025 | Cardiva Vascade 6/7f Vcs |
| Inari Medical, INC. | $20.82 | 2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Heartflow, INC. | $19.66 | 2025 | |
| Recor Medical INC | $19.53 | 2025 | Paradise Ultrasound Renal Denervation System |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Scpharmaceuticals INC. | $19.40 | 2025 | |
| Asahi Intecc USA, INC. | $18.43 | 2024 | Peripheral Vascular |
| Janssen Pharmaceuticals, INC | $17.68 | 2024 | Xarelto |
| Terumo Medical Corporation | $17.29 | 2025 | Tr Band, Metacross Otw, Glidewire |
| Cleerly, INC. | $13.78 | 2023 | Cleerly Labs |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ragheb Harb listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.